CVS Health Corporation (CVS)

Basic

  • Market Cap

    $92.92B

  • EV

    $161.03B

  • Shares Out

    1,258.45M

  • Revenue

    $356.62B

  • Employees

    259,500

Margins

  • Gross

    14.94%

  • EBITDA

    5.17%

  • Operating

    3.95%

  • Pre-Tax

    3.13%

  • Net

    2.34%

  • FCF

    2.91%

Returns (5Yr Avg)

  • ROA

    3.81%

  • ROTA

    18.28%

  • ROE

    9.93%

  • ROCE

    8.44%

  • ROIC

    5.27%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $89.74

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $11.46B

  • Net Debt

    $67.93B

  • Debt/Equity

    1.04

  • EBIT/Interest

    5.29

Growth (CAGR)

  • Rev 3Yr

    10%

  • Rev 5Yr

    12.96%

  • Rev 10Yr

    10.9%

  • Dil EPS 3Yr

    5.76%

  • Dil EPS 5Yr

    62.45%

  • Dil EPS 10Yr

    5.61%

  • Rev Fwd 2Yr

    4.41%

  • EBITDA Fwd 2Yr

    2.3%

  • EPS Fwd 2Yr

    2.75%

  • EPS LT Growth Est

    5.24%

Dividends

  • Yield

  • Payout

    37.27%

  • DPS

    $2.42

  • DPS Growth 3Yr

    6.56%

  • DPS Growth 5Yr

    3.89%

  • DPS Growth 10Yr

    10.4%

  • DPS Growth Fwd 2Yr

    7.94%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

255,765

267,908

290,912

321,629

356,623

Total Revenues % Chg.

31.9%

4.7%

8.6%

10.6%

10.9%

Cost of Goods Sold, Total

211,248

219,660

239,991

267,965

303,345

Gross Profit

44,517

48,248

50,921

53,664

53,278

Selling General & Admin Expenses, Total

32,699

34,585

36,764

37,922

39,205

Other Operating Expenses, Total

32,699

34,585

36,764

37,922

39,205

Operating Income

11,818

13,663

14,157

15,742

14,073

Interest Expense, Total

-3,035

-2,907

-2,503

-2,287

-2,658

Interest And Investment Income

1,011

798

1,199

838

1,153

Net Interest Expenses

-2,024

-2,109

-1,304

-1,449

-1,505

Other Non Operating Income (Expenses)

-7

-12

-4

-4

-6

EBT, Excl. Unusual Items

9,787

11,542

12,849

14,289

12,562

Restructuring Charges

-231

-1,358

-117

-553

Merger & Related Restructuring Charges

-480

-332

-132

-487

Impairment of Goodwill

-431

Gain (Loss) On Sale Of Assets

-2,533

-349

Asset Writedown

Legal Settlements

-5,803

Other Unusual Items

-79

-1,440

-391

EBT, Incl. Unusual Items

8,997

9,770

10,537

5,836

11,173

Income Tax Expense

2,366

2,569

2,548

1,509

2,805

Earnings From Continuing Operations

6,631

7,201

7,989

4,327

8,368

Earnings Of Discontinued Operations

-9

Minority Interest

3

-13

12

-16

-24

Net Income

6,634

7,179

8,001

4,311

8,344

Preferred Dividend and Other Adjustments

5

Net Income to Common Incl Extra Items

6,629

7,179

8,001

4,311

8,344

Net Income to Common Excl. Extra Items

6,629

7,188

8,001

4,311

8,344

Total Shares Outstanding

1,302

1,310

1,322

1,300

1,288

Weighted Avg. Shares Outstanding

1,301

1,309

1,319

1,312

1,285

Weighted Avg. Shares Outstanding Dil

1,305

1,314

1,329

1,323

1,290

EPS

5.1

5.5

6.1

3.3

6.5

EPS Diluted

5.1

5.5

6

3.3

6.5

EBITDA

16,189

18,104

18,643

19,966

18,439